Recent Posts
Connect with:
Friday / May 27.
HomemiproductsIluvien Implant for DME

Iluvien Implant for DME

Iluvien (fluocinolone acetonide intravitreal implant) 0.19 mg is indicated for the treatment of diabetic macular oedema (DME) in patients who have been previously treated with corticosteroids and did not have a clinically significant rise in intraocular pressure.

Its continuous micro-dosing technology offers up to 36 months of treatment with a single implant. Iluvien comes in a pre-loaded injector system (pictured).

Contact: Specialised Therapeutics Australia (AUS) 1300 798 820 or (NZ) 9801 0299